Amicogen, Inc. (KOSDAQ: 092040)
South Korea
· Delayed Price · Currency is KRW
3,910.00
+100.00 (2.62%)
Nov 15, 2024, 9:00 AM KST
Amicogen Revenue
Amicogen had revenue of 42.67B KRW in the quarter ending June 30, 2024, with 7.84% growth. This brings the company's revenue in the last twelve months to 158.98B, down -0.64% year-over-year. In the year 2023, Amicogen had annual revenue of 159.90B with 10.82% growth.
Revenue (ttm)
158.98B
Revenue Growth
-0.64%
P/S Ratio
1.20
Revenue / Employee
706.60M
Employees
225
Market Cap
218.99B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 159.90B | 15.61B | 10.82% |
Dec 31, 2022 | 144.30B | 19.41B | 15.55% |
Dec 31, 2021 | 124.88B | 9.02B | 7.79% |
Dec 31, 2020 | 115.86B | 675.18M | 0.59% |
Dec 31, 2019 | 115.18B | 20.66B | 21.86% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition